Literature DB >> 6373553

Active-site titration of horse urinary kallikrein.

C A Sampaio, M U Sampaio, E S Prado.   

Abstract

Horse urinary kallikrein was titrated with the reagent 4-nitrophenyl 4-guanidino-benzoate. The titration was shown to be dependent upon the concentration of the titrant. This finding, which distinguishes horse urinary kallikrein from other enzymes, is explained by the relatively small ratio between its rate of acylation and deacylation (k2/k3 = 16.8) and by a low affinity of the reagent (Km = 1.16 microM). By an appropriate kinetic treatment, it was possible to establish the relationship between the hydrolysis of 4-nitrophenyl 4-guanidinobenzoate and the actual concentration of the active enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373553     DOI: 10.1515/bchm2.1984.365.1.297

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  8 in total

1.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

2.  Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.

Authors:  F C Portaro; M H Cezari; M A Juliano; L Juliano; A R Walmsley; E S Prado
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.

Authors:  D C Pimenta; J Chao; L Chao; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  Hydrolysis of somatostatin by human tissue kallikrein after the amino acid pair phe-Phe.

Authors:  D C Pimenta; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.

Authors:  Daniel C Pimenta; Sandro E Fogaça; Robson L Melo; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

6.  Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.

Authors:  Sandro E Fogaça; Robson L Melo; Daniel C Pimenta; Kazuo Hosoi; Luiz Juliano; Maria A Juliano
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

7.  Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.

Authors:  E Del Nery; J R Chagas; M A Juliano; E S Prado; L Juliano
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

8.  Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins.

Authors:  J R Chagas; F C Portaro; I Y Hirata; P C Almeida; M A Juliano; L Juliano; E S Prado
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.